News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,334 Results
Type
Article (45088)
Company Profile (468)
Press Release (705763)
Multimedia
Podcasts (148)
Webinars (23)
Section
Business (209871)
Career Advice (2050)
Deals (36313)
Drug Delivery (142)
Drug Development (84971)
Employer Resources (174)
FDA (16944)
Job Trends (15256)
News (356031)
Policy (33432)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2706)
Accelerated approval (54)
Adcomms (37)
Allergies (180)
Alliances (51285)
ALS (223)
Alzheimer's disease (1873)
Antibody-drug conjugate (ADC) (510)
Approvals (17307)
Artificial intelligence (718)
Autoimmune disease (326)
Automation (57)
Bankruptcy (375)
Best Places to Work (11856)
BIOSECURE Act (21)
Biosimilars (230)
Biotechnology (325)
Bladder cancer (207)
Brain cancer (78)
Breast cancer (801)
Cancer (6198)
Cardiovascular disease (519)
Career advice (1744)
Career pathing (45)
CAR-T (351)
CDC (59)
Celiac Disease (3)
Cell therapy (966)
Cervical cancer (50)
Clinical research (73637)
Collaboration (2219)
Company closure (5)
Compensation (1455)
Complete response letters (93)
COVID-19 (2818)
CRISPR (118)
C-suite (1205)
Cystic fibrosis (163)
Data (8286)
Decentralized trials (3)
Denatured (46)
Depression (178)
Dermatology (94)
Diabetes (612)
Diagnostics (7039)
Digital health (57)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (353)
Drug pricing (215)
Drug shortages (32)
Duchenne muscular dystrophy (308)
Earnings (93550)
Editorial (71)
Employer branding (21)
Employer resources (153)
Events (124142)
Executive appointments (1130)
FDA (20801)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1828)
Gene editing (257)
Generative AI (58)
Gene therapy (791)
GLP-1 (1124)
Government (4864)
Grass and pollen (6)
Guidances (412)
Healthcare (19453)
HIV (84)
Huntington's disease (58)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (106)
Immunology and inflammation (329)
Immuno-oncology (106)
Indications (198)
Infectious disease (3177)
Inflammatory bowel disease (232)
Inflation Reduction Act (17)
Influenza (140)
Intellectual property (304)
Interviews (319)
IPO (16998)
IRA (53)
Job creations (3726)
Job search strategy (1444)
JPM (67)
Kidney cancer (21)
Labor market (104)
Layoffs (608)
Leadership (42)
Legal (8047)
Liver cancer (106)
Longevity (34)
Lung cancer (818)
Lymphoma (445)
Machine learning (61)
Management (59)
Manufacturing (1096)
MASH (208)
Medical device (14105)
Medtech (14238)
Mergers & acquisitions (20580)
Metabolic disorders (1608)
mRNA (242)
Multiple sclerosis (200)
NASH (20)
Neurodegenerative disease (460)
Neuropsychiatric disorders (118)
Neuroscience (3502)
Neurotech (1)
NextGen: Class of 2026 (6778)
Non-profit (4612)
Now hiring (79)
Obesity (760)
Opinion (317)
Ovarian cancer (235)
Pain (269)
Pancreatic cancer (321)
Parkinson's disease (393)
Partnered (34)
Patents (615)
Patient recruitment (714)
Peanut (64)
People (61189)
Pharmaceutical (80)
Pharmacy benefit managers (34)
Phase 1 (23134)
Phase 2 (32463)
Phase 3 (24011)
Pipeline (9210)
Policy (341)
Postmarket research (2638)
Preclinical (9918)
Press Release (67)
Prostate cancer (327)
Psychedelics (64)
Radiopharmaceuticals (356)
Rare diseases (1175)
Real estate (6088)
Recruiting (71)
Regulatory (26178)
Reports (56)
Research institute (2526)
Resumes & cover letters (355)
Rett syndrome (39)
RNA editing (27)
RSV (88)
Schizophrenia (188)
Series A (310)
Series B (227)
Service/supplier (11)
Sickle cell disease (121)
Special edition (29)
Spinal muscular atrophy (174)
Sponsored (49)
Startups (3842)
State (2)
Stomach cancer (21)
Supply chain (132)
Tariffs (88)
The Weekly (99)
Vaccines (1148)
Venture capital (120)
Weight loss (496)
Women's health (132)
Worklife (21)
Date
Today (36)
Last 7 days (623)
Last 30 days (3406)
Last 365 days (31063)
2026 (14083)
2025 (31170)
2024 (36403)
2023 (41127)
2022 (52433)
2021 (56873)
2020 (55015)
2019 (47514)
2018 (35794)
2017 (33186)
2016 (32485)
2015 (38531)
2014 (32328)
2013 (27245)
2012 (29335)
2011 (29974)
2010 (28150)
Location
Africa (760)
Alabama (99)
Alaska (7)
Arizona (362)
Arkansas (16)
Asia (41552)
Australia (6919)
California (13799)
Canada (3861)
China (1450)
Colorado (588)
Connecticut (611)
Delaware (418)
Europe (91609)
Florida (2064)
Georgia (440)
Hawaii (3)
Idaho (63)
Illinois (1103)
India (93)
Indiana (617)
Iowa (25)
Japan (564)
Kansas (135)
Kentucky (52)
Louisiana (46)
Maine (76)
Maryland (1642)
Massachusetts (9970)
Michigan (374)
Minnesota (747)
Mississippi (6)
Missouri (148)
Montana (35)
Nebraska (29)
Nevada (145)
New Hampshire (89)
New Jersey (3621)
New Mexico (32)
New York (3583)
North Carolina (1805)
North Dakota (10)
Northern California (6924)
Ohio (409)
Oklahoma (23)
Oregon (44)
Pennsylvania (2755)
Puerto Rico (29)
Rhode Island (51)
South America (1129)
South Carolina (86)
South Dakota (2)
Southern California (5418)
Tennessee (216)
Texas (2186)
United States (48778)
Utah (409)
Vermont (1)
Virginia (332)
Washington D.C. (82)
Washington State (1126)
West Virginia (4)
Wisconsin (135)
Wyoming (2)
751,334 Results for "inhibitor therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HotSpot Therapeutics to Present Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026
May 20, 2026
·
1 min read
Press Releases
Avenzo Therapeutics Announces First Patient Dosed in Combination Cohort Evaluating CDK4 Selective Inhibitor (AVZO-023) with CDK2 Selective Inhibitor (AVZO-021) In Ongoing Phase 1/2 ORION-1 Study
May 28, 2026
·
2 min read
Press Releases
Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026
April 28, 2026
·
3 min read
Press Releases
Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting
May 22, 2026
·
5 min read
Press Releases
Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome
April 1, 2026
·
5 min read
Press Releases
858 Therapeutics Announces Initial Data from First-in-Human Phase 1/2 Trial of PARG Inhibitor ETX-19477 to be Presented at 2026 ASCO Annual Meeting
May 22, 2026
·
3 min read
Press Releases
STORM Therapeutics to Present Promising Phase 1 Sarcoma Data Demonstrating Activity of First‑in‑Class METTL3 Inhibitor STC‑15 at ASCO 2026
May 22, 2026
·
5 min read
Press Releases
Avenzo Therapeutics Advances the Combination of CDK4 Selective Inhibitor (AVZO-023) with CDK2 Selective Inhibitor (AVZO-021) in Ongoing Phase 1/2 ORION-1 Study in HR+/HER2- Breast Cancer
April 28, 2026
·
3 min read
Press Releases
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
March 2, 2026
·
6 min read
Press Releases
Actuate Therapeutics Launches Strategic Research Initiative to Combine Elraglusib with RAS Inhibitors
March 9, 2026
·
7 min read
1 of 75,134
Next
